Anesthesiology and Pain Medicine

Published by: Kowsar

The Basic Study of the Mechanism of Propofol-Related Infusion Syndrome Using a Murine Skeletal Muscle Injury Model

Yuryo Murakami 1 , Ryusuke Ueki 1 , * , Taihei Tachikawa 2 and Munetaka Hirose 1
Authors Information
1 Department of Anesthesiology and Pain Medicine, Hyogo College of Medicine, Nishinomiya, Japan
2 Department of Anesthesiology, Meiwa Hospital, Nishinomiya, Japan
Article information
  • Anesthesiology and Pain Medicine: June 30, 2019, 9 (3); e89417
  • Published Online: April 23, 2019
  • Article Type: Research Article
  • Received: January 17, 2019
  • Revised: March 5, 2019
  • Accepted: April 7, 2019
  • DOI: 10.5812/aapm.89417

To Cite: Murakami Y, Ueki R, Tachikawa T , Hirose M. The Basic Study of the Mechanism of Propofol-Related Infusion Syndrome Using a Murine Skeletal Muscle Injury Model, Anesth Pain Med. 2019 ; 9(3):e89417. doi: 10.5812/aapm.89417.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998;8(6):491-9. doi: 10.1046/j.1460-9592.1998.00282.x. [PubMed: 9836214].
  • 2. Schroeppel TJ, Fabian TC, Clement LP, Fischer PE, Magnotti LJ, Sharpe JP, et al. Propofol infusion syndrome: A lethal condition in critically injured patients eliminated by a simple screening protocol. Injury. 2014;45(1):245-9. doi: 10.1016/j.injury.2013.05.004. [PubMed: 23742861].
  • 3. Krajcova A, Waldauf P, Andel M, Duska F. Propofol infusion syndrome: A structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398. doi: 10.1186/s13054-015-1112-5. [PubMed: 26558513]. [PubMed Central: PMC4642662].
  • 4. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62(7):690-701. doi: 10.1111/j.1365-2044.2007.05055.x. [PubMed: 17567345].
  • 5. Ilyas MI, Balacumaraswami L, Palin C, Ratnatunga C. Propofol infusion syndrome in adult cardiac surgery. Ann Thorac Surg. 2009;87(1):e1-3. doi: 10.1016/j.athoracsur.2008.07.055. [PubMed: 19101256].
  • 6. Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: A clinical update. Crit Care Res Pract. 2015;2015:260385. doi: 10.1155/2015/260385. [PubMed: 25954513]. [PubMed Central: PMC4410753].
  • 7. Timpe EM, Eichner SF, Phelps SJ. Propofol-related infusion syndrome in critically ill pediatric patients: Coincidence, association, or causation? J Pediatr Pharmacol Ther. 2006;11(1):17-42. doi: 10.5863/1551-6776-11.1.17.
  • 8. Uezono S, Hotta Y, Takakuwa Y, Ozaki M. Acquired carnitine deficiency: A clinical model for propofol infusion syndrome? Anesthesiology. 2005;103(4):909. doi: 10.1097/00000542-200510000-00046. [PubMed: 16192800].
  • 9. Vanlander AV, Okun JG, de Jaeger A, Smet J, De Latter E, De Paepe B, et al. Possible pathogenic mechanism of propofol infusion syndrome involves coenzyme q. Anesthesiology. 2015;122(2):343-52. doi: 10.1097/ALN.0000000000000484. [PubMed: 25296107].
  • 10. Rigoulet M, Devin A, Averet N, Vandais B, Guerin B. Mechanisms of inhibition and uncoupling of respiration in isolated rat liver mitochondria by the general anesthetic 2,6-diisopropylphenol. Eur J Biochem. 1996;241(1):280-5. doi: 10.1111/j.1432-1033.1996.0280t.x. [PubMed: 8898917].
  • 11. Branca D, Roberti MS, Vincenti E, Scutari G. Uncoupling effect of the general anesthetic 2,6-diisopropylphenol in isolated rat liver mitochondria. Arch Biochem Biophys. 1991;290(2):517-21. doi: 10.1016/0003-9861(91)90575-4. [PubMed: 1656882].
  • 12. Bains R, Moe MC, Vinje ML, Berg-Johnsen J. Sevoflurane and propofol depolarize mitochondria in rat and human cerebrocortical synaptosomes by different mechanisms. Acta Anaesthesiol Scand. 2009;53(10):1354-60. doi: 10.1111/j.1399-6576.2009.02047.x. [PubMed: 19650805].
  • 13. Mehta N, DeMunter C, Habibi P, Nadel S, Britto J. Short-term propofol infusions in children. Lancet. 1999;354(9181):866-7. doi: 10.1016/S0140-6736(05)75936-5. [PubMed: 10485752].
  • 14. Chidambaran V, Costandi A, D'Mello A. Propofol: A review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015;29(7):543-63. doi: 10.1007/s40263-015-0259-6. [PubMed: 26290263]. [PubMed Central: PMC4554966].
  • 15. Felix LM, Correia F, Pinto PA, Campos SP, Fernandes T, Videira R, et al. Propofol affinity to mitochondrial membranes does not alter mitochondrial function. Eur J Pharmacol. 2017;803:48-56. doi: 10.1016/j.ejphar.2017.03.044. [PubMed: 28341344].
  • 16. Bellanti F, Mirabella L, Mitarotonda D, Blonda M, Tamborra R, Cinnella G, et al. Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1alpha activation in hepatic ischemia/reperfusion injury. Free Radic Biol Med. 2016;96:323-33. doi: 10.1016/j.freeradbiomed.2016.05.002. [PubMed: 27154980].
  • 17. Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013;23(9):785-93. doi: 10.1111/pan.12158. [PubMed: 23534340]. [PubMed Central: PMC3711963].
  • 18. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med. 2003;29(9):1417-25. doi: 10.1007/s00134-003-1905-x. [PubMed: 12904852].
  • 19. Shiozaki K, Harasaki Y, Fukuda M, Yoshinaga A, Ryuzono S, Chigwechokha PK, et al. Positive regulation of myoblast differentiation by medaka Neu3b sialidase through gangliosides desialylation. Biochimie. 2016;123:65-72. doi: 10.1016/j.biochi.2016.01.010. [PubMed: 26805383].
  • 20. De Proost I, Pintelon I, Brouns I, Kroese AB, Riccardi D, Kemp PJ, et al. Functional live cell imaging of the pulmonary neuroepithelial body microenvironment. Am J Respir Cell Mol Biol. 2008;39(2):180-9. doi: 10.1165/rcmb.2008-0011OC. [PubMed: 18367726]. [PubMed Central: PMC2643220].
  • 21. Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: A systematic review and meta-analysis. BMC Anesthesiol. 2018;18(1):162. doi: 10.1186/s12871-018-0632-3. [PubMed: 30409186]. [PubMed Central: PMC6225663].
  • 22. White PF. Propofol: its role in changing the practice of anesthesia. Anesthesiology. 2008;109(6):1132-6. doi: 10.1097/ALN.0b013e31818ddba8. [PubMed: 19034110].
  • 23. Lim A, Braat S, Hiller J, Riedel B. Inhalational versus propofol-based total intravenous anaesthesia: practice patterns and perspectives among Australasian anaesthetists. Anaesth Intensive Care. 2018;46(5):480-7. doi: 10.1177/0310057X1804600509. [PubMed: 30189822].
  • 24. Felmet K, Nguyen T, Clark RS, Orr D, Carcillo J. The FDA warning against prolonged sedation with propofol in children remains warranted. Pediatrics. 2003;112(4):1002-3. author reply 1002-3. doi: 10.1542/peds.112.4.1002. [PubMed: 14523206].
  • 25. Kido K, Ito H, Yamamoto Y, Makita K, Uchida T. Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes. J Anesth. 2018;32(1):120-31. doi: 10.1007/s00540-017-2441-0. [PubMed: 29288336]. [PubMed Central: PMC5797219].
  • 26. Sumi C, Okamoto A, Tanaka H, Nishi K, Kusunoki M, Shoji T, et al. Propofol induces a metabolic switch to glycolysis and cell death in a mitochondrial electron transport chain-dependent manner. PLoS One. 2018;13(2). e0192796. doi: 10.1371/journal.pone.0192796. [PubMed: 29447230]. [PubMed Central: PMC5813975].
  • 27. McKune CM, Brosnan RJ, Dark MJ, Haldorson GJ. Safety and efficacy of intramuscular propofol administration in rats. Vet Anaesth Analg. 2008;35(6):495-500. doi: 10.1111/j.1467-2995.2008.00418.x. [PubMed: 18980630].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments